Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Net Income

Acadia Pharmaceutica Net Income Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Net Income from 2010 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Acadia Pharmaceutica Net Income for the quarter ending June 06, 2020 was $-42m a 0.39% decrease of 0m year over year
  • Acadia Pharmaceutica Net Income for the last 12 months ending June 06, 2020 was $-225m a -10.01% increase of 23m year over year
  • Acadia Pharmaceutica Annual Net Income for 2019 was $-235m a -4.22% increase of 10m from 2018
  • Acadia Pharmaceutica Annual Net Income for 2018 was $-245m a -18.03% increase of 44m from 2017
  • Acadia Pharmaceutica Annual Net Income for 2017 was $-289m a 6.22% decrease of -18m from 2016
Other Income Statement Metrics:
  • Acadia Pharmaceutica EBITDA for the quarter ending December 12, 2018 was $-67m a 18.74% decrease of -12m year over year
  • Acadia Pharmaceutica Total Revenue for the quarter ending September 09, 2018 was $58m a 25.29% increase of 15m year over year
View Chart On Koyfin

Quarterly ACAD Net Income Data

06/2020$-42m
03/2020$-88m
12/2019$-53m
09/2019$-42m
06/2019$-55m
03/2019$-85m
12/2018$-65m
09/2018$-62m
06/2018$-63m
03/2018$-54m

Annual ACAD Net Income Data

2019$-235m
2018$-245m
2017$-289m
2016$-271m
2015$-164m
2014$-92m
2013$-38m
2012$-21m
2011$-23m
2010$15m